MAZE
MAZE
US5787841007
Maze Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- 167.500.000
--
Cost of Revenue -- --
--
Gross Profit -- --
--
142.899.000 109.914.000
30.0%
Operating Income -142.899.000 57.586.000
348.1%
Pretax Income -131.120.000 53.403.000
345.5%
Net Income Common Stockholders -131.120.000 3.405.000
3950.8%
-- --
--
-- --
--
ende